- Home
- IBOC vs ACLX Comparison
IBOC vs ACLX Comparison
Compare IBOC & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBOC
- ACLX
- Stock Information
- Founded
- IBOC 1966
- ACLX 2015
- Country
- IBOC United States
- ACLX United States
- Employees
- IBOC N/A
- ACLX N/A
- Industry
- IBOC Major Banks
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- IBOC Finance
- ACLX Health Care
- Exchange
- IBOC Nasdaq
- ACLX Nasdaq
- Market Cap
- IBOC 4.2B
- ACLX 4.4B
- IPO Year
- IBOC N/A
- ACLX 2022
- Fundamental
- Price
- IBOC $64.74
- ACLX $87.28
- Analyst Decision
- IBOC
- ACLX Strong Buy
- Analyst Count
- IBOC 0
- ACLX 8
- Target Price
- IBOC N/A
- ACLX $115.50
- AVG Volume (30 Days)
- IBOC 222.9K
- ACLX 398.8K
- Earning Date
- IBOC 11-06-2025
- ACLX 11-05-2025
- Dividend Yield
- IBOC 2.17%
- ACLX N/A
- EPS Growth
- IBOC 5.13
- ACLX N/A
- EPS
- IBOC 6.76
- ACLX N/A
- Revenue
- IBOC $821,716,000.00
- ACLX $35,898,000.00
- Revenue This Year
- IBOC N/A
- ACLX N/A
- Revenue Next Year
- IBOC N/A
- ACLX $220.95
- P/E Ratio
- IBOC $9.70
- ACLX N/A
- Revenue Growth
- IBOC 2.80
- ACLX N/A
- 52 Week Low
- IBOC $54.11
- ACLX $47.86
- 52 Week High
- IBOC $76.91
- ACLX $103.66
- Technical
- Relative Strength Index (RSI)
- IBOC 39.46
- ACLX 51.54
- Support Level
- IBOC $64.65
- ACLX $85.00
- Resistance Level
- IBOC $67.05
- ACLX $91.68
- Average True Range (ATR)
- IBOC 1.57
- ACLX 3.99
- MACD
- IBOC -0.14
- ACLX -0.21
- Stochastic Oscillator
- IBOC 13.59
- ACLX 35.97
About IBOC International Bancshares Corporation
International Bancshares Corp is a multibank financial holding company. The company provides commercial and retail banking services in Texas and Oklahoma. The services provided by the bank include checking, savings, bank cards, lending, insurance, mortgage, investments, and other services.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.